BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 28244803)

  • 21. A Simulation Screening Mammography Module Created for Instruction and Assessment: Radiology Residents vs National Benchmarks.
    Poot JD; Chetlen AL
    Acad Radiol; 2016 Nov; 23(11):1454-1462. PubMed ID: 27637285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer detection with short-interval follow-up compared with return to annual screening in patients with benign stereotactic or US-guided breast biopsy results.
    Johnson JM; Johnson AK; O'Meara ES; Miglioretti DL; Geller BM; Hotaling EN; Herschorn SD
    Radiology; 2015 Apr; 275(1):54-60. PubMed ID: 25423143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance Benchmarks for Screening Breast MR Imaging in Community Practice.
    Lee JM; Ichikawa L; Valencia E; Miglioretti DL; Wernli K; Buist DSM; Kerlikowske K; Henderson LM; Sprague BL; Onega T; Rauscher GH; Lehman CD
    Radiology; 2017 Oct; 285(1):44-52. PubMed ID: 28582633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are radiologists' goals for mammography accuracy consistent with published recommendations?
    Jackson SL; Cook AJ; Miglioretti DL; Carney PA; Geller BM; Onega T; Rosenberg RD; Brenner RJ; Elmore JG
    Acad Radiol; 2012 Mar; 19(3):289-95. PubMed ID: 22130089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of first mammography examination in women younger than 40 years.
    Yankaskas BC; Haneuse S; Kapp JM; Kerlikowske K; Geller B; Buist DS;
    J Natl Cancer Inst; 2010 May; 102(10):692-701. PubMed ID: 20439838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the Utility of Screening Mammography for High-Risk Women Undergoing Screening Breast MR Imaging.
    Lo G; Scaranelo AM; Aboras H; Ghai S; Kulkarni S; Fleming R; Bukhanov K; Crystal P
    Radiology; 2017 Oct; 285(1):36-43. PubMed ID: 28586291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Range of Radiologist Performance in a Population-based Screening Cohort of 1 Million Digital Mammography Examinations.
    Salim M; Dembrower K; Eklund M; Lindholm P; Strand F
    Radiology; 2020 Oct; 297(1):33-39. PubMed ID: 32720866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of Risk Category and Screening Round on the Performance of an MR Imaging and Mammography Screening Program in Carriers of the BRCA Mutation and Other Women at Increased Risk.
    Vreemann S; Gubern-Mérida A; Schlooz-Vries MS; Bult P; van Gils CH; Hoogerbrugge N; Karssemeijer N; Mann RM
    Radiology; 2018 Feb; 286(2):443-451. PubMed ID: 29040037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women.
    May DS; Lee NC; Nadel MR; Henson RM; Miller DS
    AJR Am J Roentgenol; 1998 Jan; 170(1):97-104. PubMed ID: 9423608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The positive predictive value for diagnosis of breast cancer full-field digital mammography versus film-screen mammography in the diagnostic mammographic population.
    Seo BK; Pisano ED; Kuzmiak CM; Koomen M; Pavic D; McLelland R; Lee Y; Cole EB; Mattingly D; Lee J
    Acad Radiol; 2006 Oct; 13(10):1229-35. PubMed ID: 16979072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Additional double reading of screening mammograms by radiologic technologists: impact on screening performance parameters.
    Duijm LE; Groenewoud JH; Fracheboud J; de Koning HJ
    J Natl Cancer Inst; 2007 Aug; 99(15):1162-70. PubMed ID: 17652282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Immediate Interpretation of Screening Tomosynthesis Mammography on Performance Metrics.
    Winkler NS; Freer P; Anzai Y; Hu N; Stein M
    Acad Radiol; 2019 Feb; 26(2):210-214. PubMed ID: 29748047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Criteria for identifying radiologists with acceptable screening mammography interpretive performance on basis of multiple performance measures.
    Miglioretti DL; Ichikawa L; Smith RA; Bassett LW; Feig SA; Monsees B; Parikh JR; Rosenberg RD; Sickles EA; Carney PA
    AJR Am J Roentgenol; 2015 Apr; 204(4):W486-91. PubMed ID: 25794100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of ductal carcinoma in situ in women undergoing screening mammography.
    Ernster VL; Ballard-Barbash R; Barlow WE; Zheng Y; Weaver DL; Cutter G; Yankaskas BC; Rosenberg R; Carney PA; Kerlikowske K; Taplin SH; Urban N; Geller BM
    J Natl Cancer Inst; 2002 Oct; 94(20):1546-54. PubMed ID: 12381707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proposed biopsy performance benchmarks for MRI based on an audit of a large academic center.
    Sedora Román NI; Mehta TS; Sharpe RE; Slanetz PJ; Venkataraman S; Fein-Zachary V; Dialani V
    Breast J; 2018 May; 24(3):319-324. PubMed ID: 28833841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Harmonizing Breast Cancer Screening Recommendations: Metrics and Accountability.
    Lee CS; Moy L; Friedewald SM; Sickles EA; Monticciolo DL
    AJR Am J Roentgenol; 2018 Feb; 210(2):241-245. PubMed ID: 29045178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of a Risk-Based Approach for Triaging Mammography Examinations During Periods of Reduced Capacity.
    Miglioretti DL; Bissell MCS; Kerlikowske K; Buist DSM; Cummings SR; Henderson LM; Onega T; O'Meara ES; Rauscher GH; Sprague BL; Tosteson ANA; Wernli KJ; Lee JM; Lee CI
    JAMA Netw Open; 2021 Mar; 4(3):e211974. PubMed ID: 33764423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcome assessment in mammography: an audit of 7,506 screening and diagnostic mammography examinations.
    Tunçbilek I; Ozdemir A; Gültekin S; Oğur T; Erman R; Yüce C
    Diagn Interv Radiol; 2007 Dec; 13(4):183-7. PubMed ID: 18092288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrasound as the Primary Screening Test for Breast Cancer: Analysis From ACRIN 6666.
    Berg WA; Bandos AI; Mendelson EB; Lehrer D; Jong RA; Pisano ED
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26712110
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.